Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) — The “Polynucleotides Injectable Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The Polynucleotides Injectable Market was valued at USD 132.75 Million in 2024, and is expected to reach USD 231.26 Million by 2030, rising at a CAGR of 9.65%. The global polynucleotides injectable market is primarily driven by the growing demand for non-invasive, effective, and innovative treatments in dermatology, aesthetic procedures, and wound healing.
The increasing awareness of skin rejuvenation and a rising preference for minimally invasive procedures among consumers further fuel market growth. Advancements in biotechnology and the growing adoption of polynucleotide-based therapies in medical applications, such as wound care and musculoskeletal injuries, contribute to the market’s expansion. The market is also benefiting from rising disposable incomes, particularly in developed and emerging economies.
Market Drivers
- Growing Demand for Anti-Aging Treatments
- Rising Awareness of Skin Health and Aesthetics
- Increasing Adoption of Aesthetic Medicine Among Younger Populations
- Regenerative and Healing Properties
- Rising Disposable Incomes and Access to Aesthetic Procedures
- Improved Clinical Outcomes and Safety Profiles
Market Challenges
- High Cost of Treatment
- Limited Awareness and Education
- Regulatory Challenges
Market Trends
- Advancements in Biotechnology
- Non-Invasive and Effective Treatment Options
North America is the dominant region in the global polynucleotide injectable market, driven by a combination of factors, including advanced healthcare infrastructure, a high level of consumer awareness, and significant demand for non-invasive aesthetic treatments. The United States, in particular, plays a crucial role in this dominance, with a large and growing market for cosmetic procedures. The demand for polynucleotide injectables in North America is largely fueled by the increasing number of consumers seeking minimally invasive treatments to address signs of aging, such as wrinkles, fine lines, and skin laxity. In addition, consumers in the region are more inclined to explore new and innovative skincare treatments, and polynucleotide injectables, with their regenerative properties and ability to enhance skin texture, are seen as an attractive option for facial rejuvenation.
The widespread acceptance of aesthetic procedures and the strong presence of established aesthetic and cosmetic centers, med spas, and dermatology clinics further contribute to North America’s market dominance. These establishments are well-equipped with state-of-the-art technologies and highly trained practitioners who administer polynucleotide injectables, ensuring safe and effective results. As the market for non-invasive aesthetic treatments continues to grow, North America remains a leader in the adoption and advancement of injectables, including polynucleotides.
North America’s advanced biotechnology and pharmaceutical sectors have played a significant role in the development, manufacturing, and distribution of polynucleotide injectables. The region benefits from strong research and development capabilities that drive innovation in cosmetic treatments, making new and advanced options like polynucleotide injectables readily available to a large consumer base. The growing demand for natural-looking results with minimal downtime, combined with the region’s high disposable income, has led to a robust market for aesthetic injectables.
Key Players Profiled in the Polynucleotides Injectable Market
- PharmaResearch
- Bioplus Co. Ltd.
- AMEELA
- Mastelli Srl
- MD Skin Solutions
- Fox Pharma Ltd.
- BRPHARM Co. Ltd.
- DermaFocus Ltd.
- ADM Skin Clinic
- The Doctor & Company
Report Scope
Polynucleotides Injectable Market, By Application:
- Eyes
- Lips
- Forehead
- Jawline & Cheekbones
- Others
Polynucleotides Injectable Market, By End Use:
- Med Spas
- Aesthetic & Cosmetic Centers
- Others
Polynucleotides Injectable Market, By Region:
- North America
- Mexico
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Key Attributes
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $132.75 Million |
| Forecasted Market Value (USD) by 2030 | $231.26 Million |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/luegoq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Polynucleotides Injectable Market
